Bone densitometry manufacturer Norland Medical Systems turned in financial results for the first quarter (end-March) that showed none of the problems that have been dogging other bone-mass measurement companies in recent weeks. For the period,
Bone densitometry manufacturer Norland Medical Systems turned in financial results for the first quarter (end-March) that showed none of the problems that have been dogging other bone-mass measurement companies in recent weeks. For the period, Norland had sales of $4.8 million, up 134% compared with $2.1 million in the first quarter of 1998. The firms net loss shrank to $615,000, compared with a net loss of $1.9 million in the same period the year before. Norland executives said the companys numbers should improve even further as it begins recognizing revenue from its new Excell dual-energy x-ray absorptiometry axial scanner, which began shipping in March.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.